Insights - BIO

Menu

Areas of Work

	Publication Of Human Genome Sequence Launches New Era In Medicine Feb 12 2001 WASHINGTON, D.C. (February 12, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on announcements today that Science and Nature...
	BIO Urges Bush To Continue Moratorium On Cloning Human Beings Feb 1 2001 WASHINGTON, D.C. (February 1, 2001) – Following recent announcements by certain groups of plans to clone human beings, the Biotechnology Industry Organization (BIO) today sent a letter to President...
	BIO Letter on Cloning to President Bush Feb 1 2001 The Honorable George W. BushPresident of the United StatesThe White House1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President: Recently certain groups have...
	BIO Says Bush Proposal On Medicare Drug Plan Moves Debate In Positive Direction Jan 30 2001 WASHINGTON, DC (January 30, 2001) –Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on President George W. Bush’s Immediate Helping Hand...
	BIO’s CEO & Investor Conference Features Companies Leading Industry’s Financial Surge On Wall Street Jan 25 2001 WASHINGTON, D.C. (January 25, 2001) – The BiotechnologyIndustry Organization’s (BIO) CEO & Investor Conference next month in New York will showcase the companies whose technological and biomedical...
	BIO Supportive of FDA Announcement on Biotech Foods Jan 17 2001 (Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today regarding a notice of an FDA proposed rule published in today’s Federal Register....
	BIO Raises Concerns About FDA’s Proposed Rule On Disclosure Of Gene Therapy Trial Data Jan 17 2001 WASHINGTON, D.C. (January 17, 2001) -- Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the U.S. Food and Drug Administration’s (FDA)...
	BIO names Sharon L. Cohen, senior health policy strategist, as new Vice-President Jan 9 2001 BIO seeks strong role in Medicare debate WASHINGTON, D.C. (January 9, 2001) – The Biotechnology Industry Organization (BIO) today named Sharon L. Cohen BIO’s first vice president for...
	BIO Issues Statement On PTO’s Final Gene-Based Patent Guidelines Jan 5 2001 WASHINGTON, D.C. (January 5, 2001) - Lila Feisee, director of intellectual property for the Biotechnology Industry Organization (BIO), issued the following statement on the U.S. Patent and...
	CEO & Investor Conference Expected to Attract 1,500 Biotech Leaders and Investors Dec 22 2000 WASHINGTON, D.C. (December 22, 2000) - The Biotechnology Industry Organization (BIO) will host the third annual CEO & Investor Conference, "Investing in Biotechnology: The Value, The Risks,...